Lenox Wealth Advisors’s DexCom DXCM Stock Holding History

Lenox Wealth Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$3K	Buy	24 +8	+50%	+$875	﹤0.01%	600
2021 Q4	$2K	Buy	16 +12	+300%	+$1.72K	﹤0.01%	710
2021 Q3	$1K	Buy	+4	New	+$504	﹤0.01%	662
2020 Q3	–	Sell	-48	Closed	-$5K	–	586
2020 Q2	$5K	Hold	48	–	–	﹤0.01%	429
2020 Q1	$3K	Buy	+48	New	+$2.99K	﹤0.01%	495

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Lenox Wealth Advisors's DXCM Position: Q1 2022 in Review

Lenox Wealth Advisors increased its DexCom (DXCM) stake by 50% in Q1 2022, buying an estimated $875 and bringing the position to 24 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #600.

Lenox Wealth Advisors first reported a position in DXCM in Q1 2020 and has held it in 5 quarters since. The position peaked at $5K in Q2 2020. 862 funds tracked by Wall St. Rank hold DXCM as of Q1 2022.

Lenox Wealth Advisors held 24 shares of DexCom worth $3K as of Q1 2022.
Lenox Wealth Advisors bought 8 DexCom shares in Q1 2022, an estimated $875.
DexCom made up ﹤0.01% of Lenox Wealth Advisors's portfolio in Q1 2022, its #600 holding.
Lenox Wealth Advisors first reported a position in DexCom in Q1 2020 and has held it in 5 quarters since.
Lenox Wealth Advisors's DexCom position peaked at $5K in Q2 2020.
862 funds tracked by Wall St. Rank held DexCom as of Q1 2022.

Based on Lenox Wealth Advisors's 13F filing for Q1 2022, filed 14 Apr 2022.